Epidermal growth factor-induced hepatocellular carcinoma: Gene expression profiles in precursor lesions, early stage and solitary tumours

Oncogene

Volumn 24, Issue 11, 2005, Pages 1809-1819

  Borlak, Jürgen ^a   Meier, Tatiana ^a   Halter, Roman ^a   Spanel, Reinhard ^b   Spanel Borowski, Katharina ^c  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b Institute of Pathology   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

EGF; Gene expression profiling; HCC; Transgenic mice; Tumour stages

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CLAUDIN 7; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; GROWTH ARREST SPECIFIC PROTEIN 1; INHIBITOR OF DIFFERENTIATION 1; MINOPONTIN; MITOGENIC AGENT; PROTEIN C FOS; PROTEIN C JUN; RIBONUCLEOTIDE REDUCTASE; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; VILLIN; ETS2 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; TGIF PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSGENIC MOUSE; TUMOR VOLUME; UNINDEXED SEQUENCE; ANIMAL; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; ONCOGENE; PATHOLOGY; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MURINAE; MUS MUSCULUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; EPIDERMAL GROWTH FACTOR; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; HOMEODOMAIN PROTEINS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 16244407731     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208196     Document Type: Article

References (32)

1. Alvarez CV, Shon KJ, Miloso M and Beguinot L. (1995). J. Biol. Chem., 270, 16271-16276.
2. Chavrier P, Janssen-Timmen U, Mattei MG, Zerial M, Bravo R and Charnay P. (1989). Mol. Cell. Biol., 9, 787-797.
3. Chen S, Zhou B, He F and Yen Y. (2000). Antisense Nucleic Acid Drug Dev., 10, 111-116.
4. Choi S, Kobayashi M, Wang J, Habelhah H, Okada F, Hamada J, Moriuchi T, Totsuka Y and Hosokawa M. (2000). Clin. Exp. Metastasis, 18, 45-50.
5. Chung YH, Kim JA, Song BC, Lee GC, Koh MS, Lee YS, Lee SG and Suh DJ. (2000). Cancer, 89, 977-982.
6. Clark EA, Golub TR, Lander ES and Hynes RO. (2000). Nature, 406, 532-535.
7. Del Sal G, Collavin L, Ruaro ME, Edomi P, Saccone S, Valle GD and Schneider C. (1994). Proc. Natl. Acad. Sci. USA, 91, 1848-1852.
8. Del Sal G, Ruaro EM, Utrera R, Cole CN, Levine AJ and Schneider C. (1995). Mol. Cell. Biol., 15, 7152-7160.
9. Dey A, Nebert DW and Ozato K. (1991). DNA Cell Biol., 10, 537-544.
10. Evdokiou A and Cowled PA. (1998). Exp. Cell Res., 240, 359-367.
11. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M and Hirohashi S. (2002). Pathol. Int., 52, 19-24.
12. Hogan B, Beddingtin R, Costantini F and Lacy E. (1994). Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY.
13. Fahmy RG, Dass CR, Sun LQ, Chesterman CN and Khachigian LM. (2003). Nat. Med., 9, 1026-1032.
14. Kimura K, Tsuji T, Takada Y, Miki T and Narumiya S. (2000). J. Biol. Chem., 275, 17233-17236.
15. Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein C and Manns M. (2000). Liver, 20, 312-318.
16. Leu JI, Grissey MA and Taub R. (2003). J. Clin. Invest., 111, 129-139.
17. Melhuish TA, Gallo CM and Wotton D. (2001). J. Biol. Chem., 216, 32109-32114.
18. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y. (2001). Cancer Res., 61, 2129-2137.
19. Ostrowski J, Woszczynski M, Kowalczyk P, Wocial T, Hennig E, Trzeciak L, Janik P and Bomsztyk K. (2000). Br. J. Cancer, 82, 1041-1050.
20. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW and Wong YC. (2002). Carcinogenesis, 23, 721-725.
21. Ramljak D, Jones AB, Diwan BA, Perantoni AO, Hochadel JF and Anderson LM. (1998). Cancer Res., 58, 3590-3597.
22. Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C and Baffet G. (2001). Mol. Biol. Cell., 12, 725-738.
23. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL and Lee DC. (1993). Mol. Cell. Biol., 13, 320-330.
24. Schafer DF and Sorrell MF. (1999). Lancet, 35, 1253-1257.
25. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Takeda K and Akira S. (1999). Gene, 231, 59-65.
26. Tan JE, Wong SC, Gan SK, Xu S and Lam KP. (2001). J. Biol. Chem., 276, 20055-20063.
27. Tatsumoto T, Xie X, Blumenthal R, Okamoto I and Miki T. (1999). J. Cell. Biol., 147, 921-928.
28. Tönjes RR, Lohler J, OíSullivan JF, Kay GF, Schmidt GH, Dalemans W, Pavirani A and Paul D. (1995). Oncogene, 10, 755-758.
29. Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA and Baumann H. (1999). Hepatology, 30, 682-697.
30. Yamaguchi K, Carr BI and Nalesnik MA. (1995). J. Surg. Oncol., 58, 240-245.
31. Witz IP. (2000). J. Cell. Biochem. Suppl., 34, 61-66.
32. Wu JC, Merlino G, Cveklova K, Mosinger Jr B and Fausto N. (1994). Cancer Res., 54, 5964-5973.